{
    "code": "02016271",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02016271",
    "time": "2019-10-25 03:27:13",
    "許可證字號": "衛署藥輸字第016271號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "114\/01\/20",
    "發證日期": "77\/01\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201627108",
    "中文品名": "速避凝注射液",
    "英文品名": "FRAXIPARINE INJECTION",
    "適應症": "血栓性栓塞症及其預防、抗凝血。與ＡＳＰＩＲＩＮ併用治療急性非穩定性心絞痛和非Ｑ波型心肌梗塞。",
    "劑型": "27D注射液劑",
    "包裝": "注射針筒",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "NADROPARINE CALCIUM",
    "主製造廠": {
        "申請商名稱": "6401022326  安沛國際有限公司",
        "申請商地址": "台北市大安區敦化南路二段207號20樓",
        "主製造廠": "",
        "製造廠名稱": "FFR0260000  ASPEN NOTRE DAME DE BONDEVILLE"
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012401510",
            "成分名稱": "NADROPARINE CALCIUM",
            "含量描述": "9500",
            "含量": "9500.0000000000",
            "單位": "IU-AX"
        }
    ],
    "仿單外盒": [
        {
            "title": "020162710006___20110628.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02016271&Seq=010&Type=9"
        },
        {
            "title": "020162710002-中文貼標___20110721.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02016271&Seq=013&Type=8"
        }
    ]
}